Home/Filings/4/0000950170-25-048491
4//SEC Filing

Groenewald Ferdinand 4

Accession 0000950170-25-048491

CIK 0001107421other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:05 PM ET

Size

5.5 KB

Accession

0000950170-25-048491

Insider Transaction Report

Form 4
Period: 2025-03-29
Groenewald Ferdinand
Vice President of Finance
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-29+3,0003,000 total
    Exercise: $1.46Exp: 2035-03-28Common Stock (3,000 underlying)
Footnotes (1)
  • [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 29, 2025, with the first vesting occurring on June 29, 2025 subject to the Reporting Person's continued service through each vesting date.

Documents

1 file

Issuer

Alaunos Therapeutics, Inc.

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001734018

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:05 PM ET
Size
5.5 KB